CC-90001, a c-Jun N-Terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: Design of a phase 2, randomised, placebo-controlled trial

Medicine and Dentistry

• Idiopathic Pulmonary Fibrosis 100%
• Interstitial Lung Disease 100%
• Patient 66%
• Inpatient 66%
• Amino Terminal Sequence 50%
• Therapeutic Procedure 50%
• Placebo 50%
• Phosphotransferase Inhibitor 33%
• Follow up 16%
• Phenotype 16%
• Screening 16%
• Fibrosis 16%
• Programmed Cell Death 16%
• Serositis 16%
• Fibroblast 16%
• Collagen 16%
• Disease Exacerbation 16%
• Forced Vital Capacity 16%
• Epithelial Cell 16%
• Phosphotransferase 16%
• Placebo-Controlled Study 16%
• Pulmonary Fibrosis 16%
• Pirfenidone 16%
• Analysis 16%
• Arm 16%
• Polarization 16%
• Amaurosis 16%
• Macrophage 16%